Clinical Trial Update: Sequential Application of Yisaipu® and DMARDs in Treating Mild-to-Moderate AS [Phase 4]

View source ↗

Summary

Phase 4 trial update on sequential use of Yisaipu and DMARDs for treating mild-to-moderate ankylosing spondylitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ankylosing Spondylitis

Drugs mentioned

• Yisaipu (etanercept biosimilar (assumed; if Yisaipu is a biosimilar of etanercept, otherwise provide as given))

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: Ankylosing Spondylitis | Phase 4 | Status: COMPLETED